Skip to main content
Top
Published in: Acta Diabetologica 2/2021

01-02-2021 | Atrial Fibrillation | Review Article

Left atrial function in diabetes: does it help?

Authors: Marijana Tadic, Cesare Cuspidi

Published in: Acta Diabetologica | Issue 2/2021

Login to get access

Abstract

Left atrial (LA) structural, functional and mechanical changes have important role in development of diabetic cardiomyopathy and it was discovered that LA remodeling has important prognostic role in the patients with diabetes (DM). Previously the focus of echocardiographic studies in DM population was on the left ventricular structure and function, but the atrioventricular coupling was proved to be one of the main predictors of cardiovascular morbidity and mortality in DM patients. Each phase of LA cycle has determinant role in the atrioventricular coupling and therefore the accurate assessment of LA phasic function gained importance over last decade. The failure of any of the three LA phasic functions (reservoir, conduit or contractile) leads potentially to LA dilatation, left ventricular diastolic dysfunction, atrial fibrillation and ultimately development of heart failure with preserved (or even reduced) ejection fraction. Even though LA phasic function has not been extensively studied in DM population, it is reasonable to hypothesize that LA dysfunction is very frequent in these patients, considering the high prevalence of atrial fibrillation and heart failure in these individuals. In research and clinical purposes two techniques have been used for determination of LA phasic function: volumetric and strain. Although these methods fundamentally differ, with their own advantages and limitations, they also provide comparable results that can direct our therapeutic approach in DM patients. Namely, not only that LA function represents an independent predictor of cardiovascular outcome in DM patients, but also it has been also associated with parameters of glycemic control. This review summarized the current knowledge regarding LA phasic function in DM patients.
Literature
1.
go back to reference Mondillo S, Cameli M, Caputo ML et al (2011) Early detection of left atrial strain abnormalities by speckle-tracking in hypertensive and diabetic patients with normal left atrial size. J Am Soc Echocardiogr 24(8):898–908PubMedCrossRef Mondillo S, Cameli M, Caputo ML et al (2011) Early detection of left atrial strain abnormalities by speckle-tracking in hypertensive and diabetic patients with normal left atrial size. J Am Soc Echocardiogr 24(8):898–908PubMedCrossRef
2.
go back to reference Antoni ML, Ten Brinke EA, Marsan NA, Atary JZ, Holman ER, van der Wall EE et al (2011) Comprehensive assessment of changes in left atrial volumes and function after ST-segment elevation acute myocardial infarction: role of two-dimensional speckle-tracking strain imaging. J Am Soc Echocardiogr 24:1126–1133PubMedCrossRef Antoni ML, Ten Brinke EA, Marsan NA, Atary JZ, Holman ER, van der Wall EE et al (2011) Comprehensive assessment of changes in left atrial volumes and function after ST-segment elevation acute myocardial infarction: role of two-dimensional speckle-tracking strain imaging. J Am Soc Echocardiogr 24:1126–1133PubMedCrossRef
3.
go back to reference Obokata M, Negishi K, Kurosawa K, Arima H, Tateno R, Ui G et al (2013) Incremental diagnostic value of la strain with leg lifts in heart failure with preserved ejection fraction. JACC Cardiovasc Imaging 6:749–758CrossRefPubMed Obokata M, Negishi K, Kurosawa K, Arima H, Tateno R, Ui G et al (2013) Incremental diagnostic value of la strain with leg lifts in heart failure with preserved ejection fraction. JACC Cardiovasc Imaging 6:749–758CrossRefPubMed
4.
5.
go back to reference Obokata M, Negishi K, Kurosawa K, Tateno R, Tange S, Arai M et al (2014) Left atrial strain provides incremental value for embolism risk stratification over CHA(2)DS(2)-VASc score and indicates prognostic impact in patients with atrial fibrillation. J Am Soc Echocardiogr 27(709–16):e4 Obokata M, Negishi K, Kurosawa K, Tateno R, Tange S, Arai M et al (2014) Left atrial strain provides incremental value for embolism risk stratification over CHA(2)DS(2)-VASc score and indicates prognostic impact in patients with atrial fibrillation. J Am Soc Echocardiogr 27(709–16):e4
6.
go back to reference Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39PubMedCrossRef Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39PubMedCrossRef
7.
go back to reference Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17(12):1321–1360CrossRefPubMed Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17(12):1321–1360CrossRefPubMed
8.
go back to reference Pieske B, Tschöpe C, de Boer RA et al (2019) How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 40(40):3297–3317PubMedCrossRef Pieske B, Tschöpe C, de Boer RA et al (2019) How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 40(40):3297–3317PubMedCrossRef
9.
go back to reference Rønningen PS, Berge T, Solberg MG, Enger S, Nygard S, Pervez MO et al (2020) Sex differences and higher upper normal limits for left atrial end-systolic volume in individuals in their mid-sixties: data from the ACE 1950 study. Eur Heart J Cardiovasc Imaging. 21:501–507PubMedCrossRef Rønningen PS, Berge T, Solberg MG, Enger S, Nygard S, Pervez MO et al (2020) Sex differences and higher upper normal limits for left atrial end-systolic volume in individuals in their mid-sixties: data from the ACE 1950 study. Eur Heart J Cardiovasc Imaging. 21:501–507PubMedCrossRef
10.
go back to reference Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133PubMedCrossRef Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133PubMedCrossRef
11.
go back to reference Iguchi Y, Kimura K, Aoki J et al (2008) Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city. Circ J 72:909–913PubMedCrossRef Iguchi Y, Kimura K, Aoki J et al (2008) Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city. Circ J 72:909–913PubMedCrossRef
12.
go back to reference Nichols GA, Hillier TA, Erbey JR, Brown JB (2001) Congestive heart failure in type 2 diabetes: prevalence, incidence and risk factors. Diabetes Care 24:1614–1619PubMedCrossRef Nichols GA, Hillier TA, Erbey JR, Brown JB (2001) Congestive heart failure in type 2 diabetes: prevalence, incidence and risk factors. Diabetes Care 24:1614–1619PubMedCrossRef
13.
go back to reference Polovina M, Lund LH, Đikić D et al (2020) Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillation. Eur J Heart Fail 22(1):113–125PubMedCrossRef Polovina M, Lund LH, Đikić D et al (2020) Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillation. Eur J Heart Fail 22(1):113–125PubMedCrossRef
14.
go back to reference Chirinos JA, Sardana M, Ansari B et al (2018) Left atrial phasic function by magnetic resonance feature tracking is a strong predictor of incident cardiovascular events. Circ Cardiovasc Imaging 11(12):e007512PubMedPubMedCentralCrossRef Chirinos JA, Sardana M, Ansari B et al (2018) Left atrial phasic function by magnetic resonance feature tracking is a strong predictor of incident cardiovascular events. Circ Cardiovasc Imaging 11(12):e007512PubMedPubMedCentralCrossRef
15.
go back to reference Tadic M, Cuspidi C (2015) The influence of type 2 diabetes on left atrial remodeling. Clin Cardiol 38(1):48–55PubMedCrossRef Tadic M, Cuspidi C (2015) The influence of type 2 diabetes on left atrial remodeling. Clin Cardiol 38(1):48–55PubMedCrossRef
16.
go back to reference Zoppini G, Bonapace S, Bergamini C et al (2016) Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function. Nutr Metab Cardiovasc Dis 26(11):1026–1032PubMedCrossRef Zoppini G, Bonapace S, Bergamini C et al (2016) Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function. Nutr Metab Cardiovasc Dis 26(11):1026–1032PubMedCrossRef
17.
go back to reference Atas H, Kepez A, Atas DB et al (2014) Effects of diabetes mellitus on left atrial volume and functions in normotensive patients without symptomatic cardiovascular disease. J Diabetes Complicat 28(6):858–862CrossRef Atas H, Kepez A, Atas DB et al (2014) Effects of diabetes mellitus on left atrial volume and functions in normotensive patients without symptomatic cardiovascular disease. J Diabetes Complicat 28(6):858–862CrossRef
18.
go back to reference Cameli M, Mandoli GE, Lisi E et al (2019) Left atrial, ventricular and atrio-ventricular strain in patients with subclinical heart dysfunction. Int J Cardiovasc Imaging 35(2):249–258PubMedCrossRef Cameli M, Mandoli GE, Lisi E et al (2019) Left atrial, ventricular and atrio-ventricular strain in patients with subclinical heart dysfunction. Int J Cardiovasc Imaging 35(2):249–258PubMedCrossRef
19.
go back to reference Liu Y, Wang K, Su D et al (2014) Noninvasive assessment of left atrial phasic function in patients with hypertension and diabetes using two-dimensional speckle tracking and volumetric parameters. Echocardiography 31(6):727–735PubMedCrossRef Liu Y, Wang K, Su D et al (2014) Noninvasive assessment of left atrial phasic function in patients with hypertension and diabetes using two-dimensional speckle tracking and volumetric parameters. Echocardiography 31(6):727–735PubMedCrossRef
20.
go back to reference Bohne LJ, Johnson D, Rose RA, Wilton SB, Gillis AM (2019) The association between diabetes mellitus and atrial fibrillation: clinical and mechanistic insights. Front Physiol 10:135PubMedPubMedCentralCrossRef Bohne LJ, Johnson D, Rose RA, Wilton SB, Gillis AM (2019) The association between diabetes mellitus and atrial fibrillation: clinical and mechanistic insights. Front Physiol 10:135PubMedPubMedCentralCrossRef
21.
go back to reference Masuda T, Muto S, Fujisawa G et al (2012) Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 302(9):H1871–H1883PubMedCrossRef Masuda T, Muto S, Fujisawa G et al (2012) Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 302(9):H1871–H1883PubMedCrossRef
22.
go back to reference Kassan M, Choi SK, Galán M et al (2013) Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes. Diabetes 62:2078–2087PubMedPubMedCentralCrossRef Kassan M, Choi SK, Galán M et al (2013) Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes. Diabetes 62:2078–2087PubMedPubMedCentralCrossRef
24.
go back to reference Thomas L, Marwick TH, Popescu BA, Donal E, Badano LP (2019) Left atrial structure and function, and left ventricular diastolic dysfunction: JACC State-of-the-Art Review. J Am Coll Cardiol 73(15):1961–1977PubMedCrossRef Thomas L, Marwick TH, Popescu BA, Donal E, Badano LP (2019) Left atrial structure and function, and left ventricular diastolic dysfunction: JACC State-of-the-Art Review. J Am Coll Cardiol 73(15):1961–1977PubMedCrossRef
25.
26.
go back to reference Hoit BD (2018) Assessment of left atrial function by echocardiography: novel insights. Curr Cardiol Rep 20(10):96PubMedCrossRef Hoit BD (2018) Assessment of left atrial function by echocardiography: novel insights. Curr Cardiol Rep 20(10):96PubMedCrossRef
27.
go back to reference Levy F, Iacuzio L, Schouver ED et al (2019) Performance of a new fully automated transthoracic three-dimensional echocardiographic software for quantification of left cardiac chamber size and function: comparison with 3 Tesla cardiac magnetic resonance. J Clin Ultrasound 47(9):546–554PubMedCrossRef Levy F, Iacuzio L, Schouver ED et al (2019) Performance of a new fully automated transthoracic three-dimensional echocardiographic software for quantification of left cardiac chamber size and function: comparison with 3 Tesla cardiac magnetic resonance. J Clin Ultrasound 47(9):546–554PubMedCrossRef
28.
go back to reference Cameli M, Mandoli GE, Loiacono F, Dini FL, Henein M, Mondillo S (2016) Left atrial strain: a new parameter for assessment of assessment of left ventricular filling pressure. Heart Fail Rev 21(1):65–76PubMedCrossRef Cameli M, Mandoli GE, Loiacono F, Dini FL, Henein M, Mondillo S (2016) Left atrial strain: a new parameter for assessment of assessment of left ventricular filling pressure. Heart Fail Rev 21(1):65–76PubMedCrossRef
29.
go back to reference Cameli M, Lisi M, Mondillo S, Padeletti M, Ballo P, Tsioulpas C, Bernazzali S, Maccherini M (2010) Left atrial longitudinal strain by speckle tracking echocardiography correlates well with left ventricular filling pressures in patients with heart failure. Cardiovasc Ultrasound 8:14PubMedPubMedCentralCrossRef Cameli M, Lisi M, Mondillo S, Padeletti M, Ballo P, Tsioulpas C, Bernazzali S, Maccherini M (2010) Left atrial longitudinal strain by speckle tracking echocardiography correlates well with left ventricular filling pressures in patients with heart failure. Cardiovasc Ultrasound 8:14PubMedPubMedCentralCrossRef
30.
go back to reference Cameli M, Sparla S, Losito M et al (2016) Correlation of left atrial strain and Doppler measurements with invasive measurement of left ventricular end-diastolic pressure in patients stratified for different values of ejection fraction. Echocardiography 33(3):398–405PubMedCrossRef Cameli M, Sparla S, Losito M et al (2016) Correlation of left atrial strain and Doppler measurements with invasive measurement of left ventricular end-diastolic pressure in patients stratified for different values of ejection fraction. Echocardiography 33(3):398–405PubMedCrossRef
31.
go back to reference Modin D, Biering-Sørensen SR, Møgelvang R, Alhakak AS, Jensen JS, Biering-Sørensen T (2019) Prognostic value of left atrial strain in predicting cardiovascular morbidity and mortality in the general population. Eur Heart J Cardiovasc Imaging 20(7):804–815PubMedCrossRef Modin D, Biering-Sørensen SR, Møgelvang R, Alhakak AS, Jensen JS, Biering-Sørensen T (2019) Prognostic value of left atrial strain in predicting cardiovascular morbidity and mortality in the general population. Eur Heart J Cardiovasc Imaging 20(7):804–815PubMedCrossRef
32.
go back to reference Markman TM, Habibi M, Venkatesh BA et al (2017) Association of left atrial structure and function and incident cardiovascular disease in patients with diabetes mellitus: results from multi-ethnic study of atherosclerosis (MESA). Eur Heart J Cardiovasc Imaging 18(10):1138–1144PubMedPubMedCentralCrossRef Markman TM, Habibi M, Venkatesh BA et al (2017) Association of left atrial structure and function and incident cardiovascular disease in patients with diabetes mellitus: results from multi-ethnic study of atherosclerosis (MESA). Eur Heart J Cardiovasc Imaging 18(10):1138–1144PubMedPubMedCentralCrossRef
33.
go back to reference Kadappu KK, Boyd A, Eshoo S et al (2012) Changes in left atrial volume in diabetes mellitus: more than diastolic dysfunction? Eur Heart J Cardiovasc Imaging 13(12):1016–1023PubMedCrossRef Kadappu KK, Boyd A, Eshoo S et al (2012) Changes in left atrial volume in diabetes mellitus: more than diastolic dysfunction? Eur Heart J Cardiovasc Imaging 13(12):1016–1023PubMedCrossRef
34.
go back to reference Nemes A, Piros GÁ, Lengyel C et al (2016) Complex evaluation of atrial dysfunction in patients with type 1 diabetes mellitus by three-dimensional speckle tracking echocardiography: results from the MAGYAR-Path Study. Anatol J Cardiol 16(8):587–593PubMed Nemes A, Piros GÁ, Lengyel C et al (2016) Complex evaluation of atrial dysfunction in patients with type 1 diabetes mellitus by three-dimensional speckle tracking echocardiography: results from the MAGYAR-Path Study. Anatol J Cardiol 16(8):587–593PubMed
35.
go back to reference Braunauer K, Pieske-Kraigher E, Belyavskiy E et al (2018) Early detection of cardiac alterations by left atrial strain in patients with risk for cardiac abnormalities with preserved left ventricular systolic and diastolic function. Int J Cardiovasc Imaging 34(5):701–711PubMed Braunauer K, Pieske-Kraigher E, Belyavskiy E et al (2018) Early detection of cardiac alterations by left atrial strain in patients with risk for cardiac abnormalities with preserved left ventricular systolic and diastolic function. Int J Cardiovasc Imaging 34(5):701–711PubMed
36.
go back to reference Wang Y, Hou D, Ma R, Ding G, Yin L, Zhang M (2016) Early detection of left atrial energy loss and mechanics abnormalities in diabetic patients with normal left atrial size: a study combining vector flow mapping and tissue tracking echocardiography. Med Sci Monit 22:958–968PubMedPubMedCentralCrossRef Wang Y, Hou D, Ma R, Ding G, Yin L, Zhang M (2016) Early detection of left atrial energy loss and mechanics abnormalities in diabetic patients with normal left atrial size: a study combining vector flow mapping and tissue tracking echocardiography. Med Sci Monit 22:958–968PubMedPubMedCentralCrossRef
37.
go back to reference Georgievska-Ismail L, Zafirovska P, Hristovski Z (2016) Evaluation of the role of left atrial strain using two-dimensional speckle tracking echocardiography in patients with diabetes mellitus and heart failure with preserved left ventricular ejection fraction. Diab Vasc Dis Res 13(6):384–394PubMedCrossRef Georgievska-Ismail L, Zafirovska P, Hristovski Z (2016) Evaluation of the role of left atrial strain using two-dimensional speckle tracking echocardiography in patients with diabetes mellitus and heart failure with preserved left ventricular ejection fraction. Diab Vasc Dis Res 13(6):384–394PubMedCrossRef
38.
go back to reference Tadic M, Ilic S et al (2015) Left and right atrial phasic function and deformation in untreated patients with prediabetes and type 2 diabetes mellitus. Int J Cardiovasc Imaging 31(1):65–76PubMedCrossRef Tadic M, Ilic S et al (2015) Left and right atrial phasic function and deformation in untreated patients with prediabetes and type 2 diabetes mellitus. Int J Cardiovasc Imaging 31(1):65–76PubMedCrossRef
39.
go back to reference Tadic M, Vukomanovic V, Cuspidi C, Suzic-Lazic J, Stanisavljevic D, Celic V (2017) Left atrial phasic function and heart rate variability in asymptomatic diabetic patients. Acta Diabetol 54(3):301–308PubMedCrossRef Tadic M, Vukomanovic V, Cuspidi C, Suzic-Lazic J, Stanisavljevic D, Celic V (2017) Left atrial phasic function and heart rate variability in asymptomatic diabetic patients. Acta Diabetol 54(3):301–308PubMedCrossRef
40.
go back to reference Vukomanovic V, Suzic-Lazic J, Celic V et al (2020) Is there association between left atrial function and functional capacity in patients with uncomplicated type 2 diabetes? Int J Cardiovasc Imaging 36(1):15–22PubMedCrossRef Vukomanovic V, Suzic-Lazic J, Celic V et al (2020) Is there association between left atrial function and functional capacity in patients with uncomplicated type 2 diabetes? Int J Cardiovasc Imaging 36(1):15–22PubMedCrossRef
41.
go back to reference Mohseni-Badalabadi R, Mehrabi-Pari S, Hosseinsabet A (2020) Evaluation of the left atrial function by two-dimensional speckle-tracking echocardiography in diabetic patients with obesity. Int J Cardiovasc Imaging 36(4):643–652PubMedCrossRef Mohseni-Badalabadi R, Mehrabi-Pari S, Hosseinsabet A (2020) Evaluation of the left atrial function by two-dimensional speckle-tracking echocardiography in diabetic patients with obesity. Int J Cardiovasc Imaging 36(4):643–652PubMedCrossRef
42.
go back to reference Hosseinsabet A, Mohseni-Badalabadi R, Moinfar A (2017) Impaired left atrial conduit function in coronary artery disease patients with poorly controlled diabetes: two-dimensional speckle-tracking echocardiographic study. J Ultrasound Med 36(1):13–23PubMedCrossRef Hosseinsabet A, Mohseni-Badalabadi R, Moinfar A (2017) Impaired left atrial conduit function in coronary artery disease patients with poorly controlled diabetes: two-dimensional speckle-tracking echocardiographic study. J Ultrasound Med 36(1):13–23PubMedCrossRef
43.
go back to reference Badano LP, Miglioranza MH, Mihăilă S et al (2016) Left atrial volumes and function by three-dimensional echocardiography: reference values, accuracy, reproducibility, and comparison with two-dimensional echocardiographic measurements. Circ Cardiovasc Imaging 9(7):e004229PubMedCrossRef Badano LP, Miglioranza MH, Mihăilă S et al (2016) Left atrial volumes and function by three-dimensional echocardiography: reference values, accuracy, reproducibility, and comparison with two-dimensional echocardiographic measurements. Circ Cardiovasc Imaging 9(7):e004229PubMedCrossRef
44.
go back to reference Badano LP, Kolias TJ, Muraru D et al (2018) Industry representatives; Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 19(6):591–600PubMedCrossRef Badano LP, Kolias TJ, Muraru D et al (2018) Industry representatives; Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 19(6):591–600PubMedCrossRef
Metadata
Title
Left atrial function in diabetes: does it help?
Authors
Marijana Tadic
Cesare Cuspidi
Publication date
01-02-2021
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 2/2021
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-020-01557-x

Other articles of this Issue 2/2021

Acta Diabetologica 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine